Onconic Therapeutics Inc. (476060)
Market Closed
15 Oct, 06:30 AM
KRX SM KRX SM Primary ₩
12,780. 00
-870
-6.3736%
₩
256.05B Market Cap
- P/E Ratio
- Div Yield
191,667 Volume
- Eps
₩ 13,650
Previous Close Want to track 476060 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Onconic Therapeutics Inc. (476060) Statistics
Valuation metrics
Market Cap 256.05B
Enterprise value 106.68B
Trailing P/E (ttm) 27.36
Forward P/E -
PEG ratio 0.39
Price/Sales (ttm) 2
Price/Book (mrq) 7.86
Enterprise Value/Revenue 1.3
Enterprise Value/EBITDA 5.63
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 190.51K
Average volume (90 days) 649.98K
Price summary
52-Week low 8,790
52-Week high 28,900
Beta -
50-Day moving average 15,483.44
200-Day moving average 16,736.34
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1.33:1
Last split Date 10 Oct 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.3%
Operating margin 0.21%
Operational effectiveness
Return on assets 0.26%
Return on equity 0.32%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1,812.57
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 534.95
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1,381.2
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 11.39%
Book value per share (mrq) 1,892.14
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
